Centogene Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Kim Stratton
Chief executive officer
€1.5m
Total compensation
| CEO salary percentage | 56.4% |
| CEO tenure | 2.4yrs |
| CEO ownership | n/a |
| Management average tenure | 2.3yrs |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
Centogene N.V.'s (NASDAQ:CNTG) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors
Feb 16
Centogene N.V. (NASDAQ:CNTG) Might Not Be As Mispriced As It Looks
Dec 21Centogene GAAP EPS of -€0.28, revenue of €10.32M
Jul 15Is Centogene (NASDAQ:CNTG) Using Debt In A Risky Way?
Nov 25Is Centogene (NASDAQ:CNTG) Using Debt Sensibly?
Jun 29Centogene reports Q1 results
Jun 16Centogene, Alector initiate EFRONT study in frontotemporal dementia
Jun 02Centogene to nominate Rene Just as CFO at the upcoming Annual General Meeting
May 26Need To Know: Analysts Are Much More Bullish On Centogene N.V. (NASDAQ:CNTG)
Apr 17What Percentage Of Centogene N.V. (NASDAQ:CNTG) Shares Do Insiders Own?
Mar 05Update: Centogene (NASDAQ:CNTG) Stock Gained 11% In The Last Year
Jan 29Is Centogene (NASDAQ:CNTG) A Risky Investment?
Dec 18Centogene reports Q3 results
Dec 16Centogene and Alnylam launch a clinical screening program targeting rare hereditary disease
Dec 08Centogene expands partnership with PTC Therapeutics in rare genetic disorder
Nov 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -€40m |
| Mar 31 2023 | n/a | n/a | -€40m |
| Dec 31 2022 | €2m | €861k | -€39m |
Compensation vs Market: Kim's total compensation ($USD1.63M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Insufficient data to compare Kim's compensation with company performance.
CEO
Kim Stratton (61 yo)
2.4yrs
Tenure
€1,527,000
Compensation
Ms. Kim Stratton serves as Chief Executive Officer at Centogene N.V. since February 18, 2022 and serves as its Member of Management Board. She served as Interim Chief Executive Officer of Centogene N.V. si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Member of Management Board | 2.4yrs | €1.53m | no data | |
| CFO, Legal & IT and Member of Management Board | 2.3yrs | €421.00k | no data | |
| Chief Medical & Genomic Officer and Member of Management Board | 1.3yrs | €174.00k | 0.042% € 4.9k | |
| Advisor | 2.4yrs | €871.00k | no data | |
| Chief Commercial Officer & GM of Pharma | 1.2yrs | no data | no data |
2.3yrs
Average Tenure
53yo
Average Age
Experienced Management: CNTG's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Member of the Supervisory Board | 7.3yrs | €20.00k | no data | |
| Independent Member of the Supervisory Board | 6.8yrs | €22.00k | no data | |
| Independent Chairman of the Supervisory Board | 4.2yrs | €984.00k | 0.27% € 31.5k | |
| Independent Member of the Supervisory Board | 3.4yrs | €47.00k | no data | |
| Independent Member of the Supervisory Board | 7.3yrs | €20.00k | no data | |
| Member of Supervisory Board | 1.4yrs | €21.00k | no data |
5.5yrs
Average Tenure
54yo
Average Age
Experienced Board: CNTG's board of directors are considered experienced (5.5 years average tenure).